Laserfiche WebLink
<br />J-14 <br /> <br /> <br />overprescribing, opioid misuse, or opioid overdoses, treating those with OUD and any <br />co-occurring SUD/MH conditions, supporting them in treatment or recovery, <br />connecting them to care, or implementing other strategies to abate the opioid <br />epidemic described in this opioid abatement strategy list. <br />4. Provide resources to staff government oversight and management of opioid abatement <br />programs. <br />K. TRAINING <br />In addition to the training referred to throughout this document, support training to abate <br />the opioid epidemic through activities, programs, or strategies that may include, but are <br />not limited to, those that: <br />1. Provide funding for staff training or networking programs and services to improve the <br />capability of government, community, and not-for-profit entities to abate the opioid <br />crisis. <br />2. Support infrastructure and staffing for collaborative cross-system coordination to <br />prevent opioid misuse, prevent overdoses, and treat those with OUD and any co- <br />occurring SUD/MH conditions, or implement other strategies to abate the opioid <br />epidemic described in this opioid abatement strategy list (e.g., health care, primary <br />care, pharmacies, PDMPs, etc.). <br />L. RESEARCH <br />Support opioid abatement research that may include, but is not limited to, the following: <br />1. Monitoring, surveillance, data collection and evaluation of programs and strategies <br />described in this opioid abatement strategy list. <br />2. Research non-opioid treatment of chronic pain. <br />3. Research on improved service delivery for modalities such as SBIRT that <br />demonstrate promising but mixed results in populations vulnerable to opioid use <br />disorders. <br />4. Research on novel harm reduction and prevention efforts such as the provision of <br />fentanyl test strips. <br />5. Research on innovative supply-side enforcement efforts such as improved detection <br />of mail-based delivery of synthetic opioids. <br />6. Expanded research on swift/certain/fair models to reduce and deter opioid misuse <br />within criminal justice populations that build upon promising approaches used to <br />address other substances (e.g., Hawaii HOPE and Dakota 24/7).